![Charles McDermott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles McDermott
Directeur/Membre du Conseil chez
EQUILLIUM, INC.
Fortune : 76 157 $ au 30/06/2026
Profil
Charles McDermott is President, Chief Executive Officer & Director at Primmune Therapeutics, Inc. since 2019.
Mr. McDermott is Chairman at Anavo Therapeutics BV.
Mr. McDermott is Independent Director at Equillium, Inc. since 2018.
Mr. McDermott is Managing Member at McDermott Consulting since 2018.
Formerly, Mr. McDermott was Director, VP-Business Development & Eye Care at Allergan, Inc. from 2005 to 2013.
Mr. McDermott was President, Director & Chief Business Officer at Impact Biomedicines, Inc. from 2017 to 2018.
Mr. McDermott was Research Scientist at Agouron Pharmaceuticals LLC.
Mr. McDermott was Principal at deCODE genetics, Inc. from 2001 to 2005.
Mr. McDermott was President & Chief Business Officer at Kala Bio, Inc. from 2014 to 2017.
Education includes graduate studies at the University of California, Santa Barbara, undergraduate studies at the University of California, Santa Cruz, and an MBA from the University of San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EQUILLIUM, INC. 0,04 % | 28/05/2026 | 23 799 ( 0,04 % ) | 76 157 $ | 30/06/2026 |
Postes actifs de Charles McDermott
| Sociétés | Poste | Début |
|---|---|---|
| EQUILLIUM, INC. | Directeur/Membre du Conseil | 01/09/2018 |
Primmune Therapeutics, Inc.
 Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy | Directeur Général | 01/03/2019 |
Anavo Therapeutics BV
 Anavo Therapeutics BV BiotechnologyHealth Technology Operates as biotechnology company which develops therapeutic programs | Président | - |
McDermott Consulting
 McDermott Consulting Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | 01/09/2018 |
Anciens postes connus de Charles McDermott
| Sociétés | Poste | Fin |
|---|---|---|
Impact Biomedicines, Inc.
 Impact Biomedicines, Inc. Medical SpecialtiesHealth Technology Develops therapies for patients with life threatening malignancies | President | 01/05/2018 |
| KALA BIO, INC. | President | 07/08/2017 |
| ALLERGAN, INC. | Directeur/Membre du Conseil | 01/05/2013 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Corporate Officer/Principal | 01/03/2005 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Corporate Officer/Principal | - |
Formation de Charles McDermott
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology Is a bio-pharmaceutical company | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Cruz
 University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McDermott Consulting
McDermott Consulting Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Impact Biomedicines, Inc.
Impact Biomedicines, Inc. Medical SpecialtiesHealth Technology Develops therapies for patients with life threatening malignancies | Health Technology |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy | Commercial Services |
Equillium, Inc.
 Equillium, Inc. BiotechnologyHealth Technology Engages in the development of products for severe immune-inflammatory disorders | Health Technology |
Anavo Therapeutics BV
Anavo Therapeutics BV BiotechnologyHealth Technology Operates as biotechnology company which develops therapeutic programs | Health Technology |
